| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Hansa Biopharma AB (publ) (ST: HNSA)
HNSA Technical Analysis
3
| As on 27th Nov 2025 HNSA STOCK Price closed @ 34.80 and we RECOMMEND Buy for LONG-TERM with Stoploss of 28.72 & Buy for SHORT-TERM with Stoploss of 31.48 we also expect STOCK to react on Following IMPORTANT LEVELS. |
HNSASTOCK Price
| Open | 33.00 | Change | Price | % |
| High | 34.94 | 1 Day | 1.92 | 5.84 |
| Low | 33.00 | 1 Week | 8.78 | 33.74 |
| Close | 34.80 | 1 Month | -1.02 | -2.85 |
| Volume | 879122 | 1 Year | 2.26 | 6.95 |
| 52 Week High 42.74 | 52 Week Low 21.12 | ||||
ST Sweden Most Active Stocks
| ENERS | 0.00 | % |
| LIPI | 0.22 | -4.35% |
| QUIA | 0.00 | % |
| WYLD | 0.00 | % |
| SOLT | 0.16 | 6.67% |
| LUNE | 21.97 | 6.65% |
| POLY | 0.04 | 0.00% |
| IMMNOV | 0.26 | -7.14% |
| ACTI | 0.06 | 0.00% |
| EURA | 0.01 | 0.00% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
| HNSA Daily Charts |
HNSA Intraday Charts |
Whats New @ Bazaartrend |
HNSA Free Analysis |
|
|
HNSA Important Levels Intraday
| RESISTANCE | 38.54 |
| RESISTANCE | 37.34 |
| RESISTANCE | 36.60 |
| RESISTANCE | 35.86 |
| SUPPORT | 33.74 |
| SUPPORT | 33.00 |
| SUPPORT | 32.26 |
| SUPPORT | 31.06 |
HNSA Forecast November 2025
| 4th UP Forecast | 58.58 |
| 3rd UP Forecast | 50.95 |
| 2nd UP Forecast | 46.24 |
| 1st UP Forecast | 41.53 |
| 1st DOWN Forecast | 28.07 |
| 2nd DOWN Forecast | 23.36 |
| 3rd DOWN Forecast | 18.65 |
| 4th DOWN Forecast | 11.02 |
HNSA Weekly Forecast
| 4th UP Forecast | 39.85 |
| 3rd UP Forecast | 38.23 |
| 2nd UP Forecast | 37.23 |
| 1st UP Forecast | 36.23 |
| 1st DOWN Forecast | 33.37 |
| 2nd DOWN Forecast | 32.37 |
| 3rd DOWN Forecast | 31.37 |
| 4th DOWN Forecast | 29.75 |
HNSA Forecast2025
| 4th UP Forecast | 79.89 |
| 3rd UP Forecast | 65.43 |
| 2nd UP Forecast | 56.49 |
| 1st UP Forecast | 47.55 |
| 1st DOWN Forecast | 22.05 |
| 2nd DOWN Forecast | 13.11 |
| 3rd DOWN Forecast | 4.17 |
| 4th DOWN Forecast | -10.29 |
Hansa Biopharma AB (publ) ( ST Sweden Symbol : HNSA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
HNSA Business Profile
Hansa Biopharma AB (publ), a biopharmaceutical company, develops immunomodulatory treatments for enabling transplants and rare immunoglobulin G (IgG)-mediated autoimmune conditions, gene therapy, and cancer using its proprietary enzyme technology platform. The company's lead drug candidate is Imlifidase, an IgG-degrading enzyme of Streptococcus pyogenes (IdeS), an antibody cleaving enzyme that is in Phase II for enabling kidney transplantations in sensitized patients, as well as for anti-GBM antibody disease and Guillain Barré syndrome. It is also developing Novel immunoglobulin cleaving enzymes for Repeat dosing (NiceR) for the treatment of autoimmune diseases, transplantation, and oncology; and Enzyme based antibody Enhancement (EnzE), a cancer immunotherapy. The company has a preclinical research collaboration agreement with argenx BV to evaluate the therapeutic potential of combining the two companies' IgG-modulating technologies. Hansa Biopharma AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden. Address: Scheelevägen 22, Lund, Sweden, 222 63
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service